NIPER-R
NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India

Dr. Rahul Shukla, was awarded his PhD degree from J.N.U, New Delhi during which he worked at CSIR- CDRI, Lucknow as CSIR fellow. He was awarded with D.S Kothari Post Doctoral Fellowship in Medical Sciences in 2015. He received his M. Pharm (Pharmaceutics) from IIT (BHU), Varanasi and B. Pharm degree from Jamia Hamdard, Delhi. He qualified GATE, conducted by I.I.T with AIR-6 having 99.96 percentile. He worked at Dr Reddys Lab, Hyderabad as Formulation Scientist. Before joining NIPER-Raebareli he also taught at Panjab University, Chandigarh. He has published more than a dozen of research papers in International Journals, International Book Chapters and delivered invited talk at many national & international platforms such as University of Queensland, Brisbane Australia, IIT Guwahati, Lyotalk-2017, Hyderabad etc.
Research Gate Profile

Publications:

  1. Handa Mayank, Ankur Sharma, Rahul K. Verma, Rahul Shukla.  "Polycaprolactone based nano-carrier for co-administration of moxifloxacin and rutin and its In-vitro evaluation for sepsis",  2019, 54. (Web Link)

  2. Ajit Singh, Kalpesh Vaishagya, Rahul K. Verma, Rahul Shukla "Temperature/pH-Triggered PNIPAM-Based Smart Nanogel System Loaded With Anastrozole Delivery for Application in Cancer Chemotherapy". AAPS PharmSciTech (2019) 20: 213. (Web Link)

  3. Vishwas P. Pardhi, Tejesh Verma, S.J.S. Flora, Hardik Chandasana and Rahul Shukla, “Nanocrystals: An Overview of Fabrication, Characterization and Therapeutic Applications in Drug Delivery” Current Pharmaceutical Design, 24, 1-18, 2019.

  4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).N. K. Garg, G. Sharma,B. Singh, P.Nirbhavane, R. K. Tyagi, Rahul Shukla, O.P. Katare, International Journal of Pharmaceutics,Vol. 517 (2017) 413–431 (Impact Factor: 3.99)

  5. Chitosan coated alginate micro particles for oral delivery of antifilarial drug and combinations for intervention in Brugia malayi induced lymphatic filariasis., R.Shukla, J.Gupta et al., RSC Advances 2015, 5, 69047–69056.(Impact factor 3.84)

  6. Emerging trend in nano-engineered polyelectrolyte based surrogate carriers for delivery of bioactives. Shukla P, Gupta G, D Singhodia,Rahul Shukla, et al., Expert opinion in Drug Delivery. 2010 Sep; 7(9):993-1011.(Impact factor 4.5)

  7. Ciprofloxacin surf-plexes in sub-micron emulsions: A novel approach to improve payload efficiency and antimicrobial efficacy, V. Jain, D Singodia, G K. Gupta, D Garg, G.B.S Keshava, Rahul Shukla, P. K. Shukla and P R. Mishra, ,International Journal of Pharmaceutics,Vol. 409 (2011) 237–244 (Impact Factor: 3.99)

  8. Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo.,P. Dwivedi, S. Kansal, M.Sharma, Rahul Shukla, A. Verma, P. Shukla, P. Tripathi, P. Gupta, D. Saini, K. Khandelwal,R. Verma, A. K. Dwivedi and P. R. Mishra,Journal of Drug Targeting, 2012 Oct 1 ,(Impact Factor 2.8)

  9. Preparation and characterization of solid lipid nanoparticles of antimalarial drug Arteether for oral administration. P. Dwivedi, R. Khatik, K. Khandelwal, Rahul Shukla, S. K Paliwal, A. K Dwivedi, P R Mishra,Journal of Biomaterials and Tissue Engineering, Vol. 4, 1–5, 2014. (Impact Factor 1.41)

  10. Formulation and characterization of Amphotericin B loaded nanostructured lipid carriers using microfluidizer, P. Tripathi, A.Verma, P.  Dwivedi, D. Sharma, V. Kumar, Rahul Shukla, V. Teja Banala, G. Pandey, S. D. Pachauri and P R Mishra, Journal of Biomaterials and Tissue Engineering 2014, Vol. 4(3), 194-197). ,(Impact Factor 1.41)

  11. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells, S K Singh, V. T. Banala, G. K. Gupta, A. Verma, Rahul Shukla, V K. Pawar, P. Tripathi, P.R Mishra,Drug Development and Industrial Pharmacy 2015;Volume 41(11),  1759-68. (Impact Factor 2.10)

  12. Microparticles of Diethylcarbamazine Citrate for the Treatment of Lymphatic Filariasis. Rahul Shukla, J. Kumar, P. Dwivedi, P. Gatla and P.R. Mishra, Asian Journal of Chemistry; Vol. 25, (2013), 302-304.

  13. Development of Nevirapine Loaded Novel Surfactant Free Polymeric Emulsion and Investigations for Its Suitability as Drug Delivery Vehicle.,D Singodia, S Kansal, A Verma, Rahul Shukla, P Shukla,P Dwivedi, V Kumar, P     Gupta, A. K. Dwivedi, and P R. Mishra.,Journal of Bionanoscience Vol.4, 66-73 (2010)

  14. Poly (lactic-co-glycolic acid) (PLGA) & Poly (caprolactone) (PCL)Nanoparticles for Sustained delivery of anti-filarial drug. Full Paper in conference Proceedings. ASP-14, Indian Institute of Technology, Guwahati.

  15. Cationic Chitosan Grafted Lipid Nanocarriers of a Chemotherapeutic Agent. Full Paper in conference Proceedings ASP-14, Indian Institute of Technology, Guwahati.

Research:

Dr. Shukla’s research focuses on Targeted Drug Delivery System, Nanomedicine, Particle Engineering, Controlled Release System for Chemotherapeutic Agents, Neglected & Tropical Diseases Therapeutics, Product Development, Polymer Sciences & Nanocrystals.

Education:

      COURSE

UNIVERSITY

        Ph. D

J.N.U, New Delhi - Central Drug Research Institute, Lucknow

        M. Pharm. (Pharmaceutics)

IIT,(BHU),Varanasi

         B. Pharm.

Jamia Hamdard, New Delhi

Professional Experience:

Position

Time Period

Institute/University

D.S Kothari Post Doctoral Fellow

2016-18

UIPS,Panjab  University,Chandigarh

Faculty

2015-16

UIPS,Panjab  University,Chandigarh

Faculty

2014-15

SDDIP,Ambala,Haryana

CSIR-Senior Research Fellow

2011-14

Central Drug Research Institute, Lucknow

CSIR-Junior Research Fellow

2009-11

Central Drug Research Institute, Lucknow

Formulation Research & Development

2008-09

Dr Reddys Lab,IPDO,Hyderabad

Academic Achievements: